YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 337, doi. 10.1002/pros.20023
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2004 AND VI 59 AND IP 3
Results: 14
1
2
Combination therapy with vitamins C plus E inhibits survivin and human prostate cancer cell growth.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 319, doi. 10.1002/pros.20018
- By:
- Publication type:
- Article
3
Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 304, doi. 10.1002/pros.20016
- By:
- Publication type:
- Article
4
Ca<sup>2+</sup> currents in smooth muscle cells isolated from human prostate.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 275, doi. 10.1002/pros.20007
- By:
- Publication type:
- Article
5
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 243, doi. 10.1002/pros.20006
- By:
- Publication type:
- Article
6
Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 311, doi. 10.1002/pros.20017
- By:
- Publication type:
- Article
7
1α,25-dihydroxyvitamin D<sub>3</sub> induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 282, doi. 10.1002/pros.10373
- By:
- Publication type:
- Article
8
Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 268, doi. 10.1002/pros.20004
- By:
- Publication type:
- Article
9
Imaging of bioluminescent LNCaP-luc-M6 Tumors: A new animal model for the study of metastatic human prostate cancer.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 292, doi. 10.1002/pros.20003
- By:
- Publication type:
- Article
10
Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 252, doi. 10.1002/pros.20002
- By:
- Publication type:
- Article
11
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 328, doi. 10.1002/pros.10374
- By:
- Publication type:
- Article
12
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 227, doi. 10.1002/pros.10366
- By:
- Publication type:
- Article
13
Modulation of anti-adhesion molecule MUC-1 is associated with arctiin-induced growth inhibition in PC-3 cells.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 260, doi. 10.1002/pros.10364
- By:
- Publication type:
- Article
14
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression (This study was performed at Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, NSW, 2010 Australia.).
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 234, doi. 10.1002/pros.10361
- By:
- Publication type:
- Article